Teva announced the launch of Dexmethylphenidate HCl Extended-Release Capsules, the generic version of Novartis’ Focalin XR.

Dexmethylphenidate HCl is a CNS stimulant indicated for the treatment of attention deficit hyperactivity disorder (ADHD). Dexmethylphenidate, the more pharmacologically active d-enantiomer of racemic methylphenidate, is thought to block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extraneuronal space.

RELATED: ADHD Treatments

Dexmethylphenidate HCl Extended-Release Capsules are available in 15mg, 30mg, and 40mg strengths in 100-count bottles.

Continue Reading

For more information call (888) 838-2872 or visit TevaGenerics.com.

Topics:

Attention-Deficit/Hyperactivity Disorder General Psychiatry